Might Gaps in FDA Drug Oversight Be a Cause for Concern for In-Vitro Diagnostic Manufacturers and Clinical Laboratories?

As drug recalls increased over the past 12 months, questions regarding FDA oversight of drug manufacturing are triggering questions involving IVD oversight by the federal agency and potential implications for clinical laboratories Pathologists and clinical laboratory managers are following the recent recalls of popular blood pressure medications in the past six months. These issues once […]
Source: Dark Daily - Category: Laboratory Medicine Authors: Tags: Compliance, Legal, and Malpractice Laboratory News Laboratory Operations Laboratory Pathology Source Type: news